Entera Bio Ltd (NASDAQ:ENTX)’s traded shares stood at 0.12 million during the last session, with the company’s beta value hitting 1.69. At the close of trading, the stock’s price was $1.67, to imply an increase of 8.44% or $0.13 in intraday trading. The ENTX share’s 52-week high remains $1.87, putting it -11.98% down since that peak but still an impressive 68.86% since price per share fell to its 52-week low of $0.52. The company has a valuation of $59.25M, with an average of 0.26 million shares in intraday trading volume over the past 10 days and average of 146.80K shares over the past 3 months.

Entera Bio Ltd (NASDAQ:ENTX) trade information

After registering a 8.44% upside in the last session, Entera Bio Ltd (ENTX) has traded red over the past five days. The stock hit a weekly high of 1.7500, jumping 8.44% in its intraday price action. The 5-day price performance for the stock is -2.91%, and 33.60% over 30 days. With these gigs, the year-to-date price performance is 178.33%. Short interest in Entera Bio Ltd (NASDAQ:ENTX) saw shorts transact 8090.0 shares and set a 0.06 days time to cover.

Entera Bio Ltd (ENTX) estimates and forecasts

Looking at statistics comparing Entera Bio Ltd share performance against respective industry, we note that the company has underperformed competitors. Entera Bio Ltd (ENTX) shares are 132.27% up over the last 6 months, with its year-to-date growth rate lower than industry average at -141.94% against 12.70%. Revenue is forecast to shrink -50.00% this quarter before falling -75.00% for the next one.

ENTX Dividends

Entera Bio Ltd has its next earnings report out between May 03 and May 07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Entera Bio Ltd has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Entera Bio Ltd (NASDAQ:ENTX)’s Major holders

Entera Bio Ltd insiders hold 19.90% of total outstanding shares, with institutional holders owning 10.50% of the shares at 13.11% float percentage. In total, 10.50% institutions holds shares in the company, led by Knoll Capital Management, LLC. As of Jun 29, 2023, the company held over 2.48 million shares (or 8.62% of shares), all amounting to roughly $2.1 million.

The next major institution holding the largest number of shares is HRT Financial LP with 26414.0 shares, or about 0.09% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $22277.0.

Going by data provided on May 30, 2023, Fidelity NASDAQ Composite Index Fund holds roughly 17597.0 shares. This is just over 0.06% of the total shares, with a market valuation of $13954.0